Is telehealth allowed to prescribe Ozempic in Texas?

If you’re considering medications like Wegovy, Ozempic, or Mounjaro for weight loss, you’ve likely wondered: Can I actually get these prescribed through telehealth? The short answer is yes — and for many people, telehealth has become the most accessible path to evidence-based obesity treatment.

With obesity affecting over 40% of American adults and GLP-1 medications showing remarkable results (patients losing 15-20% of body weight on average), the demand for convenient access has never been higher. But navigating the rules around online prescriptions can feel overwhelming, especially with state-by-state variations and evolving regulations.

This guide breaks down everything you need to know: from federal and state laws to what you can expect during a telehealth visit, provider qualifications, and how to avoid red flags. Whether you’re just starting your research or ready to take the next step, we’ll help you understand your options clearly and safely.

Understanding Federal Telehealth Laws for Weight Loss Medications

The Good News: GLP-1 Medications Are Fully Legal to Prescribe Via Telehealth

Here’s the most important thing to know: GLP-1 weight loss medications like Wegovy, Ozempic, and Mounjaro are not controlled substances. This means they’re not subject to the federal Ryan Haight Act, which requires an in-person examination before prescribing controlled medications like Adderall or opioids.

Under federal law, licensed healthcare providers can prescribe non-controlled medications — including all FDA-approved GLP-1 medications — through telehealth appointments without any requirement for an in-person visit. This has been true even before the COVID-19 pandemic and remains unchanged today.

What About the DEA’s Telehealth Rules?

You may have heard about temporary telehealth flexibilities for controlled substances during COVID-19. The DEA extended these flexibilities through December 31, 2025, allowing providers to prescribe medications like ADHD stimulants via telehealth without an initial in-person exam. While this extension is important for mental health care, it doesn’t affect GLP-1 weight loss medications at all — those were always allowed via telehealth because they’re not controlled substances.

The key takeaway: Federal law poses no barriers to getting Wegovy, Ozempic, or Mounjaro prescribed through a legitimate telehealth service.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Variations: What You Need to Know

While federal law permits telehealth prescribing of GLP-1 medications, individual states have their own healthcare regulations that can add requirements. Most states fully embrace telehealth for weight loss treatment, but some impose additional steps to ensure patient safety.

States Requiring an Initial In-Person Exam

A handful of states require patients to have at least one in-person physical examination before or shortly after starting weight loss medication via telehealth. These include:

Arkansas: One of the most restrictive states for telemedicine overall, Arkansas typically requires an initial in-person examination to establish a valid patient-provider relationship before prescribing weight loss medications.

Delaware: Requires an initial physical exam in person before telehealth prescribing can continue.

Georgia: State medical board guidance expects an in-person evaluation prior to prescribing obesity medications via telehealth.

Mississippi: Generally requires an initial in-person visit for weight management therapy, though telehealth follow-ups are permitted.

New Jersey: Requires comprehensive in-person evaluation including physical exam, laboratory testing, and psychological screening before starting weight loss medication.

North Dakota: State medical board expects a hands-on initial evaluation for weight loss treatment, with telehealth follow-ups allowed.

South Carolina: Requires an initial in-person examination before prescribing weight loss medications through telehealth.

Texas: While telehealth is broadly allowed, standard of care typically dictates an initial in-person exam for obesity medication prescribing, though this varies by provider practice.

States With Stricter Treatment Protocols

Some states don’t require in-person visits but impose specific treatment requirements:

Florida: Requires patients to have a BMI of at least 30 (or 27 with comorbidities) and mandates follow-up visits at least every three months during treatment. Providers must document lifestyle modification attempts.

Virginia: Requires an initial comprehensive evaluation (including physical exam and lab work), a personalized diet and exercise plan, and a follow-up visit within 30 days of starting therapy.

Connecticut: Requires that obesity treatment include behavioral counseling and a documented diet and exercise plan alongside medication.

States With Full Telehealth Freedom

Many states have no special restrictions on telehealth prescribing of weight loss medications beyond standard medical care requirements:

• California
• Illinois
• New York
• Pennsylvania
• Washington
• Utah

In these states, a licensed provider can conduct your entire evaluation, prescribe medication, and provide ongoing care completely through telehealth if clinically appropriate.

How Telehealth Weight Loss Prescriptions Actually Work

The Initial Consultation

A legitimate telehealth weight loss program will never just hand you a prescription after a quick questionnaire. Here’s what to expect:

1. Comprehensive Medical History: You’ll complete a detailed intake form covering your weight history, previous weight loss attempts, current medications, medical conditions, allergies, and family history. This typically takes 15-20 minutes.

2. Live Video Consultation: You’ll meet with a licensed healthcare provider (physician, nurse practitioner, or physician assistant) via secure video. They’ll:

• Review your medical history in detail
• Discuss your weight loss goals and previous attempts
• Calculate and verify your BMI
• Screen for contraindications (like personal or family history of thyroid cancer)
• Explain how GLP-1 medications work, including realistic expectations
• Discuss common side effects and when to seek medical attention
• Review lifestyle modifications (diet, exercise, behavioral changes)
• Answer all your questions

3. Clinical Eligibility Assessment: Your provider will determine if you meet FDA criteria:

• BMI ≥ 30 (obesity), or
• BMI ≥ 27 with at least one weight-related condition (Type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea)

4. Informed Consent: You’ll review and sign consent forms acknowledging you understand the medication’s risks, benefits, alternatives, and your commitment to lifestyle changes.

Getting Your Prescription

If approved, your provider will electronically send your prescription to a licensed pharmacy (many telehealth services partner with mail-order pharmacies for convenience, though you can often choose your local pharmacy).

Initial prescriptions typically start at lower doses to assess tolerance:

• Wegovy: Start at 0.25mg weekly, gradually increasing over 16-20 weeks
• Ozempic: Usually 0.25mg weekly for 4 weeks, then increase
• Mounjaro: Begin at 2.5mg weekly, titrating up as needed

Most providers prescribe 4-week supplies initially to monitor how you respond.

Ongoing Monitoring and Follow-Up

Reputable telehealth programs require regular check-ins:

First Month: Follow-up within 2-4 weeks to assess tolerance, side effects, and initial response.

Ongoing: Check-ins every 4-12 weeks (depending on state requirements and clinical need) to:

• Monitor weight loss progress
• Adjust medication dosage
• Assess and manage side effects
• Review lifestyle adherence
• Order periodic lab work if needed
• Evaluate whether to continue, adjust, or discontinue treatment

Some states mandate specific follow-up frequencies — Florida requires at least quarterly visits, Virginia requires a 30-day follow-up, and most providers follow similar protocols regardless of state requirements because it’s good medical practice.

Provider Qualifications: Who Can Prescribe Your Medication?

Physicians (MDs and DOs)

All states allow physicians to prescribe GLP-1 weight loss medications via telehealth (assuming they’re licensed in your state). This is the most straightforward path with no regulatory complications.

Nurse Practitioners (NPs)

Nurse practitioners can prescribe these medications in all 50 states, but the level of oversight varies:

Independent Practice States (34 states + DC): NPs can evaluate, diagnose, and prescribe without physician oversight. These include California, New York, Washington, Arizona, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, North Dakota, Oregon, Rhode Island, South Dakota, Utah, Vermont, Virginia, Wisconsin, Wyoming, Alaska, and District of Columbia.

Collaborative/Supervisory States: NPs can prescribe but must have a formal agreement with a collaborating physician. Examples include Texas, Florida, Georgia, Pennsylvania, and South Carolina.

What This Means for You: If you see an NP through telehealth, they’re operating within their state’s scope of practice. Many telehealth platforms (like Klarity Health) work with NPs in states where they have full practice authority, ensuring seamless care without unnecessary bureaucratic hurdles.

Physician Assistants (PAs)

PAs can also prescribe GLP-1 medications but typically require physician collaboration or supervision in most states. The level of autonomy varies by state, with some allowing PAs significant independence and others requiring closer oversight.

Red Flag: Unlicensed or Out-of-State Providers

Critical requirement: Your provider must be licensed in the state where you physically reside during the consultation. A doctor licensed only in California cannot prescribe to you if you’re in Texas, for example. Legitimate telehealth services ensure their providers are properly licensed in all states they serve.

What Makes You Eligible for GLP-1 Weight Loss Medications?

FDA-Approved Indications

Wegovy (semaglutide 2.4mg) is FDA-approved for chronic weight management in adults with:

• BMI ≥ 30 kg/m² (obesity), or
• BMI ≥ 27 kg/m² with at least one weight-related comorbid condition (Type 2 diabetes, hypertension, dyslipidemia)

Ozempic (semaglutide 0.5-1mg) is FDA-approved for Type 2 diabetes but commonly prescribed off-label for weight loss under the same criteria as Wegovy (it’s the same active ingredient, just different dosing).

Mounjaro (tirzepatide) is FDA-approved for Type 2 diabetes. A higher-dose version called Zepbound was approved specifically for obesity in late 2023. Providers can prescribe either for weight loss if you meet clinical criteria.

Who Should NOT Take These Medications?

Reputable telehealth providers will screen for contraindications, including:

• Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) — these are absolute contraindications due to a boxed FDA warning
• Pregnancy or planning to become pregnant — GLP-1s must be stopped at least 2 months before conception
• History of pancreatitis — these medications can increase pancreatitis risk
• Severe gastroparesis or gastrointestinal disorders
• Active gallbladder disease
• Certain kidney problems — requires careful monitoring
• History of severe allergic reaction to semaglutide or tirzepatide

Beyond BMI: Clinical Judgment Matters

While BMI thresholds provide general guidance, good providers consider the full picture:

• Previous weight loss attempts: Most protocols expect you’ve tried diet and exercise
• Medical necessity: Presence of obesity-related health problems
• Mental health stability: Providers should screen for eating disorders or unrealistic expectations
• Commitment to lifestyle changes: These medications work best with diet and exercise modifications

Common Misconception: ‘I just need to lose 10 pounds for my wedding’ won’t qualify you. These are serious medications for people struggling with clinical obesity, not cosmetic weight loss tools.

What to Expect: Results, Side Effects, and Commitment

Realistic Expectations

Timeline: Weight loss is gradual. Most people lose:

• 5-10% of body weight in the first 3 months
• 15-20% over 6-12 months with consistent use
• Plateau around 12-18 months

It’s not magic: You’ll still need to make dietary changes and increase physical activity. The medication helps by reducing hunger and cravings, making lifestyle changes feel more achievable.

Common Side Effects

Most people experience some side effects, especially when starting or increasing doses:

Gastrointestinal (very common):

• Nausea (often improves after a few weeks)
• Diarrhea or constipation
• Abdominal discomfort
• Decreased appetite
• Occasional vomiting

Tips to minimize: Eat smaller portions, avoid fatty/greasy foods, stay hydrated, and give your body time to adjust.

Serious Side Effects (rare but important):

• Severe abdominal pain (could indicate pancreatitis or gallstones)
• Changes in vision
• Rapid heartbeat
• Severe allergic reactions

Your telehealth provider should give you clear guidance on when to seek immediate medical attention.

Long-Term Commitment

These medications work as long as you take them — but most people regain weight if they stop. Current research suggests many people may need to continue treatment long-term, similar to other chronic disease medications.

Cost considerations:

• With insurance: Many commercial plans now cover Wegovy or Zepbound, though prior authorizations and step therapy requirements are common. Copays typically range from $25-$300/month.
• Without insurance: Retail prices are $900-$1,500/month. Manufacturer savings programs can reduce this significantly (Novo Nordisk’s Wegovy savings card, Eli Lilly’s Mounjaro/Zepbound savings program).
• Telehealth pricing: Services like Klarity Health often negotiate better rates and accept both insurance and cash-pay options, with transparent pricing from the start.

Red Flags: How to Spot Illegitimate Telehealth Services

The popularity of GLP-1 medications has attracted some bad actors. Watch out for:

🚩 Guaranteed Prescriptions Without Proper Evaluation

Legitimate providers never guarantee you’ll get a prescription. If a service promises ‘everyone gets approved’ or doesn’t require a live video consultation with a licensed provider, run away.

🚩 Compounded or ‘Generic’ Semaglutide

As of May 2025, the FDA effectively banned compounding pharmacies from making semaglutide copies for weight loss. Any telehealth service still offering ‘compounded Wegovy’ or ‘generic Ozempic’ is operating in a legal gray area at best, and you have no guarantee of medication safety, purity, or proper dosing.

What’s allowed: FDA-approved brand-name medications from licensed U.S. pharmacies. That’s it.

🚩 No Follow-Up or Monitoring

If a service prescribes your medication and then never checks in on you, that’s dangerous. You should have scheduled follow-ups at minimum every 1-3 months.

🚩 Unclear Provider Credentials

Can you easily find out who your provider is, what their credentials are, and what state they’re licensed in? If this information is buried or missing, that’s a major red flag.

🚩 Overseas Pharmacies or Suspiciously Low Prices

Some sites offer ‘cheap Ozempic from Canada’ or similar. These medications may be:

• Counterfeit
• Improperly stored (GLP-1s require refrigeration)
• Not FDA-approved formulations
• Illegal to import

Stick with U.S.-licensed pharmacies only.

🚩 No Informed Consent or Risk Discussion

Any legitimate provider will thoroughly discuss risks, side effects, contraindications, and alternatives. If you’re rushed through or told ‘it’s totally safe for everyone,’ find a different provider.

How Klarity Health Approaches Telehealth Weight Loss Treatment

At Klarity Health, we’ve built our approach around three core principles: accessibility, safety, and transparency.

Accessible Care, Done Right

We know that for many people, traditional in-person weight loss clinics present real barriers — limited appointment times, long wait lists, geographic limitations, or stigma. Our telehealth model connects you with licensed providers across multiple states, often with appointments available within days rather than months.

But accessibility never comes at the expense of quality. Every patient receives:

• A thorough medical evaluation by a licensed MD, DO, NP, or PA
• Live video consultation (not just a questionnaire)
• Evidence-based treatment protocols
• Regular monitoring and follow-up care

Transparent Pricing Options

We accept both insurance and self-pay options:

Insurance: We work with most major insurance plans. Our team handles prior authorizations and helps you understand your coverage before you start. Many patients pay only their standard copay.

Cash Pay: For those without insurance coverage, we offer transparent, upfront pricing — no hidden fees or surprise bills. We’ll also help you access manufacturer savings programs that can significantly reduce your out-of-pocket costs.

Available When You Need Us

Our providers have availability that works around your schedule — evenings and weekends included. Follow-up appointments can happen during your lunch break via secure video, and our patient support team is available to answer questions between visits.

Multi-State Licensure

We ensure our providers are properly licensed in your state, so you can receive care that complies with all local regulations while still enjoying the convenience of telehealth.

Frequently Asked Questions

Q: How quickly can I get started with telehealth weight loss treatment?

A: Most patients can schedule an initial consultation within 3-7 days. If approved, prescriptions are typically sent to the pharmacy the same day. However, start times depend on your state’s requirements (some need lab work first), pharmacy availability, and insurance approval processes.

Q: Will my insurance cover telehealth weight loss prescriptions?

A: Coverage varies significantly by plan. As of 2025, many commercial insurance plans cover Wegovy or Zepbound for obesity, but Medicare does not cover weight loss medications (though this may change with pending legislation). Medicaid coverage varies by state. The best approach is to check with your insurance directly or work with a telehealth service that handles insurance verification.

Q: Can I use my local pharmacy or must I use mail-order?

A: You can typically choose. Many patients prefer mail-order pharmacies partnered with telehealth services for convenience and sometimes better pricing, but you can also have prescriptions sent to your local pharmacy.

Q: What happens if I move to a different state during treatment?

A: Your provider must be licensed in your new state. Most telehealth services can transfer you to a provider licensed in your new location, but there may be brief interruption. Always notify your provider before relocating.

Q: Can I get Ozempic for weight loss if I don’t have diabetes?

A: Yes, providers can prescribe Ozempic off-label for weight loss if you meet clinical criteria. However, you’ll need to provide informed consent acknowledging off-label use. Some providers prefer to prescribe Wegovy (which is FDA-approved for obesity) instead since it’s the same medication at a higher dose.

Q: Are these medications safe for long-term use?

A: Clinical trials have followed patients for 2+ years showing continued safety and effectiveness. Since obesity is a chronic condition, many experts expect patients may need long-term treatment, similar to medications for diabetes or high blood pressure. Your provider will monitor you regularly for any concerns.

Q: What if I experience side effects?

A: Contact your provider immediately if you have severe symptoms. For common mild side effects like nausea, your provider may adjust your dose, suggest timing changes, or recommend dietary modifications. Most side effects improve significantly within the first month.

Q: Can I stop and start these medications?

A: Technically yes, but it’s not ideal. Weight regain often occurs when stopping, and you’d need to restart at a low dose and retitrate up. Work with your provider on any decisions to discontinue.

Looking Ahead: The Future of Telehealth Weight Loss Treatment

The regulatory landscape continues to evolve in favor of expanded access:

Federal level: The DEA has extended telehealth flexibilities multiple times, and Congress is considering legislation (like the TREATS Act) to make certain telehealth prescribing provisions permanent. While these primarily affect controlled substances, they signal broad support for telemedicine.

State level: More states are moving toward full practice authority for nurse practitioners, which expands the provider pool for telehealth services. Several states are also eliminating or reducing restrictive in-person exam requirements that were written before modern telemedicine existed.

Clinical developments: New GLP-1 medications and combination therapies are in the pipeline, and telehealth platforms are positioned to quickly integrate these options as they receive FDA approval.

Insurance coverage: There’s growing momentum for obesity to be treated as the chronic disease it is, with corresponding pressure for better insurance coverage of effective treatments.

The bottom line: Telehealth access to evidence-based weight loss treatment is here to stay and will likely continue improving.

Taking the Next Step

If you’re struggling with obesity and considering medication, telehealth offers a legitimate, safe, and often more convenient path than traditional clinic visits. The key is choosing a reputable provider who:

✓ Conducts thorough medical evaluations
✓ Uses licensed, credentialed providers
✓ Follows evidence-based treatment protocols
✓ Provides ongoing monitoring and support
✓ Operates transparently about costs and processes
✓ Complies with all federal and state regulations

Weight loss is challenging, and there’s no shame in seeking medical help. Medications like Wegovy, Ozempic, and Mounjaro represent real medical advances that can make a meaningful difference for people with obesity — and telehealth makes accessing that care more feasible for more people.

If you’d like to explore whether you’re a candidate for telehealth weight loss treatment, Klarity Health providers are ready to help. We offer comprehensive evaluations, personalized treatment plans, transparent pricing (insurance and cash-pay options available), and ongoing support throughout your journey.

Ready to get started? Schedule a consultation with Klarity Health today to discuss your options with a licensed provider. Your path to effective weight management may be just a video call away.

Sources and References

1. DEA Announcement – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025’ (November 15, 2024). Available at: www.dea.gov

2. Axios News – ‘COVID-era telehealth prescribing extended’ (November 18, 2024). Available at: www.axios.com

3. McDermott Will & Emery Legal Analysis – ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025’ (November 18, 2024). Available at: www.mwe.com

4. Goodwin Procter Law Firm – ‘The Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs’ (March 27, 2024). Available at: www.goodwinlaw.com

5. Reuters – ‘Hims cuts 4% of workforce amid ban on weight-loss drug copies’ (May 30, 2025). Available at: www.reuters.com

This article was verified and updated as of December 17, 2025. Healthcare regulations evolve frequently; always consult with a licensed healthcare provider and verify current rules in your specific state.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid